Kevin Harrington
VietnamscientistMale9.0Global Dominance: 0.00%Professor Kevin Harrington is a prominent oncologist and researcher who led a significant clinical trial in the UK exploring the effectiveness of the immunotherapy drug pembrolizumab for treating advanced head and neck cancers. His work has been instrumental in demonstrating how this treatment could potentially double survival rates and revolutionize care for patients with these challenging cancers.
Country presence
Recent news mentions
Professor Kevin Harrington praised the drug's effectiveness in eliminating tumors as unprecedented.
Thuốc tiêm mới có thể xóa sổ khối u ung thư giai đoạn cuốiVietnam· 2026-06-01
Kevin Harrington is a professor at the London Institute of Cancer Research and an oncologist at the Royal Marsden Hospital.
Index - Tech-Tudomány - Orvosi áttörés: egy új rákellenes injekció 15 végstádiumú betegnél teljesen eltüntette a daganatot
Hungary· 2026-05-31Kevin Harrington is a professor of biological therapies against cancer at the Institute of Cancer Research in London.
Tratament împotriva cancerului cu rezultate fără precedent: injecția care poate elimina complet tumorile
Romania· 2026-05-31Kevin Harrington, professor in biological cancer therapies at the Institute of Cancer Research, discussed the unprecedented trial results of a cancer jab.
Cancer jab can eradicate entire tumours in patients, trial shows – The Irish Times
Ireland· 2026-05-30Kevin Harrington, professor in biological cancer therapies at the Institute of Cancer Research, London, hailed the trial results as unprecedented.
Cancer jab can eradicate entire tumours in patients, trial shows | Cancer research
United Kingdom· 2026-05-30Kevin Harrington is a professor of biological therapies against cancer at the British institute and discusses the benefits of the new treatment.
‘Injeção inteligente’ mostra promessa no tratamento de câncer avançado de cabeça e pescoço
Brazil· 2025-10-21
Prof Kevin Harrington is a professor of biological cancer therapies and a consultant oncologist who discussed the encouraging results of a trial for head and neck cancer treatment.
Smart jab can shrink head and neck cancer tumours within six weeks, trial finds | Cancer researchUnited Kingdom· 2025-10-19
Kevin Harrington is the Senior Director of Strategic Planning at the National Security Council and participated in the process led by Anton.
پایان همکاری مذاکره کننده ارشد آمریکا- ایران با وزارت خارجه
Iran· 2025-08-28
Kevin Harrington is one of the two senior White House officials at the Stockholm conference.
China haunts Bilderberg talks as usual suspects plot world domination | BilderbergUnited Kingdom· 2025-06-15
Kevin Harrington, a professor of biological cancer therapies at the Institute of Cancer Research, London, led a UK team involved in the trial.
‘Gift of life’: experts hail neck and head cancer breakthrough | CancerUnited Kingdom· 2025-05-31
Prof Kevin Harrington, who led the trial in the UK, explains the benefits of the immunotherapy drug pembrolizumab.
Immunotherapy drug doubles cancer survival in breakthrough trialUnited Kingdom· 2025-05-31